Table 1.
Demographic data and T2* results for the participants.
| Age (year) | Mean +- SD | 23.7 ± 11.61 |
| Median (range) | 58 | |
| Minimum | 9 | |
| Maximum | 67 | |
| Gender | Male | 19 |
| Female | 20 | |
| Ferritin (ng/dl) | Mean +- SD | 4640.75 ± 4821.93 |
| Median (range) | 19115.08 | |
| Minimum | 112.15 | |
| Maximum | 19227.23 | |
| Normal | 1 | |
| Abnormal | 38 | |
| T2*Liver (ms) | Mean +- SD | 3.84 ± 3.49 |
| Median (range) | 12.30 | |
| Minimum | 0.70 | |
| Maximum | 13.00 | |
| Normal | 2 (5.1%) | |
| Abnormal | ||
| Severe | 15 (38.5%) | |
| Moderate | 11 (28.2%) | |
| Mild | 11 (28.2%) | |
| T2*Heart (ms) | Mean +- SD | 32.04 ± 14.94 |
| Median (range) | 51.30 | |
| Minimum | 2.60 | |
| Maximum | 53.90 | |
| Normal | 30 (76.9%) | |
| Abnormal | ||
| Severe | 3 (7.7%) | |
| Moderate | 6 (15.4%) | |
| Mild | - | |
| T2*Pancreas (ms) | Mean +- SD | 18.28 ± 13.98 |
| Median (range) | 49.10 | |
| Minimum | 1.4 | |
| Maximum | 50.50 | |
| Normal | 7 (17.9%) | |
| Abnormal | ||
| Severe | 2 (5.1%) | |
| Moderate | 15 (38.5%) | |
| Mild | 15 (38.5%) |